Search Results 511-520 of 13825 for Assay

  1. Fluorescence in situ hybridization - Cytogenetics Core - Mayo Clinic Research

    Cytogenetics Core. Sections. Overview · Faculty and staff; Services Services. Services · Cell culture · Fluorescence in situ hybridization · OncoScan assay ...

  2. Laboratory dermatology - Overview - Mayo Clinic

    This enzyme-linked immunosorbent assay (ELISA) method detects and quantifies serum levels of antibodies against desmogleins 1 and 3. These autoantibodies ...

  3. Clinical trials - Oncology (Medical)

    Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. A Study to Evaluate Same Day Discharge ...

  4. Synovial Fluid Banking For Periprosthetic Joint Infection Research - Mayo Clinic

    Ensure standardized collection, processing, and storage procedures that preserve sample integrity for downstream laboratory assays. Participation ...

  5. General Internal Medicine - Clinical trials

    The purose of this study is to develop assays to ... This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay ...

  6. Clinical trials - Oncology (Medical)

    Eligible participants with mCRC will be enrolled into specific treatment arms based on their biomarker assay results. A Study to Evaluate Same Day Discharge ...

  7. Breast Cancer Clinical Trials - Mayo Clinic Research

    Assays for troponin with sensitivity into the pg/ml range have now been introduced. A majority of patients greater than age 50 have ... Proton Therapy for ...

  8. Clinical trials - Oncology (Medical)

    CfDNA Assay Prospective Observational Validation For Early Cancer Detection And Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  9. Nonendoscopic screening tools for early detection of Barrett's esophagus, esophageal adenocarcinoma and dysplasia - Mayo Clinic

    The EMERALD study aimed to develop and test a blood-based assay for ... Detection of esophageal cancer via assay of novel methylated DNA markers in plasma.

  10. Colon Adjuvant Chemotherapy Based On Evaluation Of Residual Disease - Mayo Clinic

    NOTE: Patients with pathologic stages II or IIIC colon adenocarcinoma with R0 resection who have a commercially obtained Signatera™ ctDNA+ve assay result ...